The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 4 , ISSUE 1 ( February, 2003 ) > List of Articles

RESEARCH ARTICLE

A Review of Drug-Induced Oral Reactions

Mohammad Abdollahi, Mania Radfar

Citation Information : Abdollahi M, Radfar M. A Review of Drug-Induced Oral Reactions. J Contemp Dent Pract 2003; 4 (1):10-31.

DOI: 10.5005/jcdp-4-1-10

License: CC BY-NC 3.0

Published Online: 01-02-2003

Copyright Statement:  Copyright © 2003; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Citation

Abdollahi M, Radfar M. A Review of Drug-Induced Oral Reactions. J Contemp Dent Pract 2003 February;(4)1:010-031.


PDF Share
  1. Oral and dental disorders. In:Davies DM, Ferner RE, DeGlanville H. eds., Davies's textbook of adverse drug reactions, 5th ed., London, Chapman & Hall Medical, 1998:234-250.
  2. Oral pathology clinical pathologic corrections. 3rd ed., London, W.B. Saunders Company, 1999:62-65, 158-159, 179, 181, 496.
  3. Adverse drug reactions. In:Silverman S, Eversole LR, Truelove EL. Eds., Essentials of oral medicine, London, BC Decker Inc, 2001:107-110.
  4. Chlorhexidine mouthwash-induced fixed drug eruption; case report and review of the literature. Oral Surg Oral Med Oral Pathol. 1991 Apr;71(4):431-4. Review.
  5. Drug eruption reference manual. London, The Parthenon Publishing Group, 2001:274-421.
  6. Burning mouth syndrome after taking clonazepam. Ann Pharmacother. 2001 Jul-Aug;35(7-8):874-6.
  7. al. Scalded mouth caused by angiotensin converting enzyme inhibitors. Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1672-3. No abstract available.
  8. Lisinopril-induced scalded mouth syndrome. Ann Pharmacother. 1992 Nov;26(11):1381-2.
  9. Scalded mouth syndrome caused by angiotensin converting enzyme inhibitors: two case reports. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jun;83(6):665-7.
  10. al. Oral disease, clinical and pathological correlations. 3rd ed., London, Mosby, 2001:4.13, 11.15, 12.13, 12.14, 13.18, 13.19, 13.33.
  11. al. Ginseng as a cause for Stevens-Johnson syndrome? Lancet. 1996 May 11;347(9011):1344. No abstract available.
  12. Verapamil-associated Stevens-Johnson syndrome. DICP. 1989 Dec;23(12):987-8.
  13. Letter: Mouth ulceration and slow-release potassium tablets. Br Med J. 1974 Oct 19;4(5937):164-5. No abstract available.
  14. Tetracycline-induced oral mucosal ulcerations. Ann Pharmacother. 1996 May;30(5):547-8. No abstract available.
  15. Proguanil, chloroquine, and mouth ulcers. Lancet. 1990 Jan 20;335(8682):164. No abstract available.
  16. Oral mucosal ulceration from disopyramide. Ann Pharmacother. 1995 Dec;29(12):1299-1300. No abstract available.
  17. Carranza's clinical periodontology. London, W.B. Saunders Company, 2002:281-285.
  18. Disorders of pigmentation in the oral cavity. Clin Dermatol. 2000 Sep-Oct;18(5):579-87. Review. No abstract available.
  19. 114, Disk B, 2002.
  20. al. Fundamentals of operative dentistry. 2nd ed., Chicago, Quintessence Publishing Co., 2001:402.
  21. Esthetic dentistry, a clinical approach to techniques and materials. 2nd ed., Philadelphia, Mosby, 2001:247-249.
  22. al. Minocycline-induced staining of the adult permanent dentition: a review of the literature and report of a case. Dent Update. 1999 May;26(4):160-2. Review.
  23. Clinical periodontology and implant dentistry. 3rd ed., Copenhagen, Munksgoard, 1997:346-349.
  24. al. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med. 1992 Apr;21(4):181-5.
  25. Keratinocyte growth factor receptor is up-regulated in cyclosporine-A induced gingival hyperplasia. J Dent Res. 2002 Oct;81(10):683-7.
  26. al. Cyclosporin A regulates interleukin-1beta and interleukin-6 expression in gingiva: implications for gingival overgrowth. J Periodontol. 1999 Mar;70(3):294-300.
  27. The effects of human mast-cell products and of phenytoin on androgen 5alphareductase expression in human gingival fibroblasts. Arch Oral Biol. 2001 Sep;46(9):847-55.
  28. al. Oral problems and genetic aspects of individuals with epilepsy. Periodontol 2000. 1994 Oct;6:68-78. Review. No abstract available.
  29. al. Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis. J Periodontol. 2002 Aug;73(8):861-7.
  30. al. Inhibition by nifedipine of adherence- and activated macrophageinduced death of human gingival fibroblasts. Eur J Pharmacol. 2001 Mar 9;415(1):95-103.
  31. al. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol. 1993 Apr;20(4):286-93.
  32. Effects of lithium on rat parotid and submandibulary gland functions. Gen Pharmacol. 1995 Jul;26(4):851-4.
  33. Protection by nitric oxide of morphine-induced inhibition of rat submandibular gland function. Pharmacol Res. 2002 Feb;45(2):87-92.
  34. , Rahbar-Haghighat M, Soltaninejad K. Prevention by flumazenil of benzodiazepines-suppressed rat submandibular gland function. Indian Journal of Pharmacology 2002;34:164-171.
  35. Inhibition of rat parotid and submandibular gland functions by ofloxacin, a fluoroquinolone antibiotic. Fundam Clin Pharmacol. 2001 Oct;15(5):307-11.
  36. Protection by selenium of lead-acetate-induced alterations on rat submandibular gland function. Hum Exp Toxicol. 2001 Jan;20(1):28-33.
  37. L-arginine/nitric oxide pathway and interaction with lead acetate on rat submandibular gland function. Pharmacol Toxicol. 2000 Nov;87(5):198-203.
  38. Alteration by cadmium of rat submandibular gland secretory function and the role of the L-arginine/nitric oxide pathway. Pharmacol Res. 2000 Dec;42(6):591-7.
  39. Alteration of rat submandibulary gland secretion of protein, calcium and N-acetyl-beta-D-glucosaminidase activity by lead. Gen Pharmacol. 1997 Oct;29(4):675-80.
  40. al. Effects of cyclosporine A on the functions of submandibular and parotid glands of rats. Gen Pharmacol. 1996 Jul;27(5):887-90.
  41. al. On the relation of calcium channel blockers to rat parotid and submandibular glands function in vivo. Gen Pharmacol. 1995 May;26(3):619-22.
  42. al. Effects of vinca alkaloids on rat parotid and submandibular glands function in vivo. Gen Pharmacol. 1995 Mar;26(2):321-5.
  43. Effects of gentamicin on rat submandibulary gland functions. Gen Pharmacol. 1994 Dec;25(8):1719-22.
  44. al. Lead intoxication in rats and its concentrations in blood and saliva. Toxic Subs Mech 1997;16:327-385.
  45. Alteration by rubidium of rat submandibular secretion of protein and N-acetyl-?-D-glucosaminidase. Toxic Subs Mech 1998;17:121-131.
  46. al. Alteration by lead acetate of rats submandibular gland morphology and ultrastructure. Toxic Subs Mech 1999;18:139-148.
  47. Facial swelling secondary to inhaled bronchodilator abuse: catecholamineinduced sialadenosis. Ann Allergy. 1989 Apr;62(4):289-93.
  48. Adverse drug reactions in the mouth. Clin Dermatol. 2000 Sep-Oct;18(5):525-32. Review. No abstract available.
  49. Saliva: its role in health and disease. J Clin Gastroenterol. 1988 Oct;10(5):569-78. Review.
  50. A contemporary view of salivary research. Crit Rev Oral Biol Med. 1993;4(3-4):599-604.
  51. al. Salivary gland swelling following naproxen therapy. Br J Dermatol. 1995 Oct;133(4):647-9.
  52. Sulfadiazine-induced sialadenitis. Ann Pharmacother. 1997 Jan;31(1):59-60.
  53. A suspected case of trimipramine-induced salivary adenitis. Drug Intell Clin Pharm. 1982 Mar;16(3):248-9. No abstract available.
  54. Managing the side effects of medications. J Dent Hyg. 2000 Winter;74(1):57-69; quiz 71-2. Review.
  55. al. Harrison's principles of internal medicine. 15th ed., New York, McGraw-Hill, 2001:1974.
  56. al. Morphine and dryness of the mouth. BMJ. 1989 May 6;298(6682):1222-3. No abstract available.
  57. Isotretinoin therapy for acne: a population-based study. CMAJ. 1988 Jan 1;138(1):47-50.
  58. Adverse effects profile of sulfhydryl compounds in man. Am J Med. 1986 Mar;80(3):471-6. Review.
  59. al. Effect of oral contraceptive cycle on dry socket (localized alveolar osteitis). J Am Dent Assoc. 1980 Nov;101(5):777-80.
  60. Salivary gland dysfunction: a review of systemic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):156-62. Review.
  61. Xerostomia-clinical evaluation and treatment in general practice. J Calif Dent Assoc 2000;28(12):933-941.
  62. Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist. 1994 May-Jun;14(3):96-102. Review.
  63. al. Adverse drug interactions in dental practice. Professional and educational implications. J Am Dent Assoc. 1999 Jan;130(1):47-54.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.